1002728-75-7Relevant academic research and scientific papers
INDOLEAMIDE COMPOUNDS AS AN IHNIBITOR OF CELLULAR NECROSIS
-
, (2016/11/07)
The present invention relates to a an indoleamide compound of chemical formula 1, pharmaceutically allowable salt thereof, or an isomer, to a composition for preventing or treating cellular necrosis and related diseases containing the same as an active in
MELANOCORTIN RECEPTOR AGONISTS
-
Page/Page column 11, (2010/06/11)
The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.
MELANOCORTIN RECEPTOR AGONISTS
-
Page/Page column 26, (2010/06/15)
The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.
MELANOCORTIN RECEPTOR AGONISTS
-
Page/Page column 32-33, (2008/06/13)
The present invention relates to a compound of the following formula 1, pharmaceutically acceptable salt and isomer thereof effective as agonist of melanocortin receptor, and an agonistic composition of melanocortin receptor comprising the same as active ingredient.
